Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease

NCT01039389 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Ivabradine
DRUG: Placebo

Sponsor

Insel Gruppe AG, University Hospital Bern